In vitro effects of eslicarbazepine (S-licarbazepine) as a potential precision therapy on SCN8A variants causing neuropsychiatric disorders.

Bayraktar E, Liu Y, Sonnenberg L, Hedrich UBS, Sara Y, Eltokhi A, Lyu H, Lerche H, Wuttke TV, Lauxmann S
Br J Pharmacol. 2023 Apr;180(8):1038-1055. doi: 10.1111/bph.15981. Epub 2022 Dec 19. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.